Programmed cell death protein-1 (PD-1)/programmed cell death 1 ligand-1 (PD-L1) inhibitors have certain antitumor activity on children with recurrent or refractory Hodgkin lymphoma (HL), recurrent or refractory primary mediastinal large B-cell lymphoma, unresectable or metastatic microsatellite instability-high or deficient mismatch repair solid tumor with progression after treatment, recurrent or metastatic Merkel cell carcinoma, especially in children with recurrent or refractory HL. Insufficient expression of PD-1 and PD-L1 can be used as biomarkers to select children who may respond to PD-1/PD-L1 inhibitors. Cytotoxic T lymphocyte antigen-4 inhibitors can be used for the treatment of patients aged 12 and over with unresectable tumors and metastatic melanoma. Immune checkpoint inhibitors (ICIs) are relatively safe and well tolerated. The combined application of multiple ICIs, combined with chemotherapeutic drugs, DNA methyltransferase inhibitors, CD30 antibodies and chimeric antigen receptor T-cell immunotherapy may further improve the curative effect. This article reviewed the research progress of ICIs in the treatment of pediatric hematologic malignancies and tumors in recent years, in order to provide some reference for clinical diagnosis and treatment.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |